SomaLogic Acquires DNA Nanotechnology Provider For $35M
SomaLogic Inc (NASDAQ:SLGC) has agreed to acquire Palamedrix Inc for $14 million in cash and $21 million in SomaLogic common stock. Up…
Reneo Pharmaceuticals Says Metabolic Disorder Program To Enter Next Stage Of Development
Reneo Pharmaceuticals Inc (NASDAQ:RPHM) has reported results from the REN001 long-chain fatty acid oxidation disorders (LC-FAOD) study and provided additional development…
General Motor’s Joint Venture To Receive $2.5B Government Loan For Upcoming Battery Plants In US
The U.S. Department of Energy is reviving an old low-cost loan program, and the first recipient is Ultium Cells, the joint battery venture between General Motors Company (NYSE: GM) and LG Energy Solution.
Needham Remains Bullish On UK-Based MedTech Stock Citing Upcoming Catalyst
LivaNova PLC (NASDAQ:LIVN) could provide an update on its RECOVER difficult-to-treat depression (DTD) trial within the next few months, representing a…
This Small Cap Cancer Company ‘Hijacks Tumors From Within,” HC Wainwright Says
HC Wainwright has initiated coverage on Genenta Science SpA (NASDAQ:GNTA) with a Buy rating and a price target of $25. “We like Genenta’s…
Regeneron’s Price Target Cut On Dim Prospects For Its Flagship Eye Product
SVB has cut the price target from $738 to $630 and downgraded from Outperform to Market Perform to reflect Regeneron Pharmaceutical Inc’s (NASDAQ:REGN)…
Soligenix Partners With SERB Pharmaceuticals To Supply Ricin Antigen For Ricin Toxin Poisoning Treatment
Soligenix Inc (NASDAQ:SNGX) has signed a worldwide license to supply its ricin antigen to SERB Pharmaceuticals for novel therapeutic treatment against…
Europe’s CHMP Recommends Approving AstraZeneca’s Asthma, Neuromuscular Disorder Treatments
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of AstraZeneca Plc’s (NASDAQ:AZN) Ultomiris (ravulizumab)…
Semiconductor Shortages – See How ResMed Is Tackling
ResMed Inc (NYSE: RMD) has redesigned the AirSense 10 to eliminate a short-supply semiconductor chipset used for cellular communications chips.
This Analyst Says GSK Spin-Off Haleon Offers “Best Of Both Consumer Worlds”
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p.